NLS Pharma

About:

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Website: http://nlspharma.com

Twitter/X: NLSPharma

Top Investors: Yorkville Advisors, Biotechnology Value Fund

Description:

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.

Total Funding Amount:

$30.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Stans, Nidwalden, Switzerland

Founded Date:

2015-01-01

Contact Email:

contact(AT)nls-pharma.com

Founders:

Alex Zwyer, Bruno Figadère, Eric Konofal

Number of Employees:

1-10

Last Funding Date:

2024-10-15

IPO Status:

Public

Industries:

© 2025 bioDAO.ai